Epidemiology of vancomycin-resistant enterococci in Canadian hospitals (CANWARD study, 2007 to 2013)

Canadian Antimicrobial Resistance Alliance (CARA) (2015) Epidemiology of vancomycin-resistant enterococci in Canadian hospitals (CANWARD study, 2007 to 2013). Antimicrobial Agents and Chemotherapy, 59 (7). pp. 4315-4317. ISSN 0066-4804

Full text not available from this repository.

Abstract

Of 1,927 Enterococcus species isolates collected across Canada from 2007 to 2013, 80 (4.2%) were identified as vancomycin-resistant enterococci (VRE). VRE infections during this time tripled in Canadian hospitals, from 1.8% to 6.0% (P = 0.03). All VRE were Enterococcus faecium, with 90% possessing vanA. The prevalence of vanB decreased from 37.5% in 2007 to 0% in 2013 (P < 0.05). The VRE were multidrug resistant, but 70.6%, 86.3%, and 100% were susceptible to doxycycline, linezolid, and daptomycin, respectively.

Item Type: Article
Additional Information: Publisher Copyright: © 2015, American Society for Microbiology. All rights reserved.
Uncontrolled Keywords: pharmacology,pharmacology (medical),infectious diseases,sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/3000/3004
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 14 Sep 2022 09:30
Last Modified: 23 Sep 2022 02:55
URI: https://ueaeprints.uea.ac.uk/id/eprint/88225
DOI: 10.1128/AAC.00384-15

Actions (login required)

View Item View Item